# Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis

> **NCT06139029** · EARLY_PHASE1 · COMPLETED · sponsor: **Mardan Medical Complex** · enrollment: 60 (actual)

## Conditions studied

- Acute Bronchiolitis

## Interventions

- **DRUG:** 3% normal saline
- **DRUG:** steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline

## Key facts

- **NCT ID:** NCT06139029
- **Lead sponsor:** Mardan Medical Complex
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-15
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-03-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139029, "Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06139029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*